Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention. It is published by the American Association for Cancer Research and co-sponsored by the American Society of Preventive Oncology.
| Discipline | Cancer epidemiology |
|---|---|
| Language | English |
| Edited by | Elizabeth A. Platz |
| Publication details | |
| History | 1991-present |
| Publisher | |
| Frequency | monthly[1] |
| 4.344 (2019) | |
| Standard abbreviations | |
| ISO 4 | Cancer Epidemiol. Biomark. Prev. |
| NLM | Cancer Epidemiol Biomarkers Prev |
| Indexing | |
| CODEN | CEBPE4 |
| ISSN | 1055-9965 (print) 1538-7755 (web) |
| OCLC no. | 23441645 |
| Links | |
Indexed by ISI Cancer Epidemiology, Biomarkers & Prevention collected an impact factor of 5.057 as reported in the 2018 Journal Citation Reports by Thomson Reuters, ranking it 48 out of 230 journals in the category Oncology[2] and ranking it 13 out of 186 journals in the category Public, environmental & occupational health.[3]
References
edit- ^ Reuters Master Journal List accessed Dec 03, 2009
- ^ "Journals Ranked by Impact: Oncology". 2018 Journal Citation Reports (Sciences ed.). Thomson Reuters. 2019.
{{cite book}}:|work=ignored (help) - ^ "Journals Ranked by Impact: Public, environmental & occupational health". 2018 Journal Citation Reports (Sciences ed.). Thomson Reuters. 2019.
{{cite book}}:|work=ignored (help)